According to the National Institutes of Health, approximately 500,000 people in the U.S. have been diagnosed with Parkinson’s disease (PD), and that number is expected to double by 2040.
To date, lecanemab is the first traditional approval of a treatment for Alzheimer’s disease. Lecanemab holds promise for patients in early stages of the disease.
The family of Bruce Willis recently revealed that the actor has been diagnosed with frontotemporal dementia, or FTD. While you’ve likely heard of dementia and associate the health condition with...
University of Utah Health scientists are developing a website to help those who are in the early stages of dementia share their desires for late-life medical treatment .
You are intent on going somewhere for a meaningful purpose. But when you reach your destination, you can't recall why you needed to be there. Could this common occurrence be...
Doctors aren't quite sure what causes sundowner's syndrome, but they do know people with Alzheimer's disease are prone to develop it, especially in the mid to late-stages of the disease.
An experimental Alzheimer’s drug is stirring excitement as the first to show promise in slowing the pace of dementia. King is local director for a larger clinical trial that is...
A new report from the National Health Aging Trends Study and National Study of Caregiving shows that over six million people in the U.S. provide extensive care for loved ones...
Media and the community are invited to an Open House to tour the facilities and learn about Center for Alzheimer's Research Imaging and Care, the educational resources at the Brain...
Cinluma won the $15,000 grand prize. The team of Kris Loken, Timothy Pickett, Brian Charlesworth, Jennwood Chen, Evan Howard and Ashley Langell worked together for six months, using $500, to...
